Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis

BACKGROUND: Adherence and persistence rates of anticholinergic (ACH) therapies have been well described. To date, few studies describe these metrics for mirabegron in patients with overactive bladder. METHODS: This retrospective analysis of MarketScan(®) database assessed adherence and persistence o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Clin Pract
Egile Nagusiak: Sussman, D., Yehoshua, A., Kowalski, J., Lee, W., Kish, J., Chaudhari, S., Murray, B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Urology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6680256/
https://ncbi.nlm.nih.gov/pubmed/28371019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12824
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak